Bay State Culture Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bay State Culture Daily.

Press releases published on September 3, 2026

Sep. 3, 2026

Anonymous Alerts Opens New Stamford Headquarters to Fuel School Safety Expansion

Indeterminate GlobeNewswire

Sep. 3, 2026

Publicly Traded MMA & Live Sports Promoter Xtreme One Entertainment Files 2025 Independent Audit, YTD Financials, Returns to OTCQB Full Listing

Indeterminate GlobeNewswire

Sep. 3, 2026

DP World Recognized for Emissions Transparency at Santos Terminal

Indeterminate GlobeNewswire

Sep. 3, 2026

Malbek Announces Full Agenda for Envision 2026, Featuring Exclusive Smash Mouth Concert Experience and Builds on Star-Studded Keynote Lineup

Indeterminate GlobeNewswire

Sep. 3, 2026

American Battery Materials Submits Annual BLM Maintenance Fees for 743 Lisbon Valley Mining Claims

Indeterminate GlobeNewswire

Sep. 3, 2026

Rapid7 to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Jupiter Festival Miami Unveils 2026 Agenda Examining the Future of Content and the Forces Reshaping Media, Entertainment and Sports

Indeterminate GlobeNewswire

Sep. 3, 2026

Ariat Stakes Its Claim as the Official Uniform of Football Season with New Brock Purdy and Josh Hoover Campaign

Indeterminate GlobeNewswire

Sep. 3, 2026

Prime Medicine to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Rafferty Domnick Cunningham & Yaffa Earns First-Ever Ranking in Chambers USA 2026

Indeterminate GlobeNewswire

Sep. 3, 2026

Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Veterans Share Their Stories in “Operation Onward”, a New Series Exploring Life After Military Service

Indeterminate GlobeNewswire

Sep. 3, 2026

Crescent Biopharma to Present at September Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting

Indeterminate GlobeNewswire

Sep. 3, 2026

Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation

Indeterminate GlobeNewswire

Sep. 3, 2026

Ingredient Testing Doesn't Predict a Finished Joint Supplement's Results

Indeterminate GlobeNewswire

Sep. 3, 2026

Oligonucleotide Drug Delivery Is Moving Beyond the Liver

Indeterminate GlobeNewswire

Sep. 3, 2026

Victoria’s Secret & Co. Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire

Sep. 3, 2026

C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd International Myeloma Society (IMS) Annual Meeting

Indeterminate GlobeNewswire

Sep. 3, 2026

Lands’ End Announces Second Quarter Fiscal 2026 Results

Indeterminate GlobeNewswire